Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Redbaron2211on Jan 21, 2019 11:30pm
55 Views
Post# 29262825

RE:RE:RE:52 WEEK LOW!

RE:RE:RE:52 WEEK LOW!Even for Bio this is under valued at current prices. Pressure could be from people trying to derisk possibly from the last PP as they never got a chance to sell with out a loss and now with trials in motion it's squeeze time. Ride the warrants. Anyways with no pressure it's a buyer's market so we will see how low they want to go. Just over a year ago I picked up some pretty cheap shares at .15 cents before FDA announcement would be happy to get some more freebies. Currently there is very little for IR to work with so I'm not surprised to see things lagging. That can change fast and we when it does we will see the pay off.
Bullboard Posts